285 related articles for article (PubMed ID: 14645659)
1. Differences in the central nervous system distribution and pharmacology of the mouse 5-hydroxytryptamine-6 receptor compared with rat and human receptors investigated by radioligand binding, site-directed mutagenesis, and molecular modeling.
Hirst WD; Abrahamsen B; Blaney FE; Calver AR; Aloj L; Price GW; Medhurst AD
Mol Pharmacol; 2003 Dec; 64(6):1295-308. PubMed ID: 14645659
[TBL] [Abstract][Full Text] [Related]
2. Discrimination in 5-HT(3) receptor binding in murine brain and cultured cell preparations.
Zhang ZJ; Trivedi BL; de Paulis T; Schmidt DE; Hewlett WA
Naunyn Schmiedebergs Arch Pharmacol; 2002 Feb; 365(2):123-32. PubMed ID: 11819030
[TBL] [Abstract][Full Text] [Related]
3. Identification of residues important for ligand binding to the human 5-hydroxytryptamine1A serotonin receptor.
Chanda PK; Minchin MC; Davis AR; Greenberg L; Reilly Y; McGregor WH; Bhat R; Lubeck MD; Mizutani S; Hung PP
Mol Pharmacol; 1993 Apr; 43(4):516-20. PubMed ID: 8474430
[TBL] [Abstract][Full Text] [Related]
4. Molecular cloning of human 5-hydroxytryptamine3 receptor: heterogeneity in distribution and function among species.
Miyake A; Mochizuki S; Takemoto Y; Akuzawa S
Mol Pharmacol; 1995 Sep; 48(3):407-16. PubMed ID: 7565620
[TBL] [Abstract][Full Text] [Related]
5. Possible differences in modes of agonist and antagonist binding at human 5-HT6 receptors.
Pullagurla MR; Westkaemper RB; Glennon RA
Bioorg Med Chem Lett; 2004 Sep; 14(17):4569-73. PubMed ID: 15357994
[TBL] [Abstract][Full Text] [Related]
6. Cloning and functional expression of a human 5-hydroxytryptamine type 3AS receptor subunit.
Belelli D; Balcarek JM; Hope AG; Peters JA; Lambert JJ; Blackburn TP
Mol Pharmacol; 1995 Dec; 48(6):1054-62. PubMed ID: 8848005
[TBL] [Abstract][Full Text] [Related]
7. Selective 5-HT6 receptor ligands: progress in the development of a novel pharmacological approach to the treatment of obesity and related metabolic disorders.
Heal DJ; Smith SL; Fisas A; Codony X; Buschmann H
Pharmacol Ther; 2008 Feb; 117(2):207-31. PubMed ID: 18068807
[TBL] [Abstract][Full Text] [Related]
8. Comparison of human, mouse, rat, and guinea pig histamine H4 receptors reveals substantial pharmacological species variation.
Liu C; Wilson SJ; Kuei C; Lovenberg TW
J Pharmacol Exp Ther; 2001 Oct; 299(1):121-30. PubMed ID: 11561071
[TBL] [Abstract][Full Text] [Related]
9. Characterization of Ro 04-6790 and Ro 63-0563: potent and selective antagonists at human and rat 5-HT6 receptors.
Sleight AJ; Boess FG; Bös M; Levet-Trafit B; Riemer C; Bourson A
Br J Pharmacol; 1998 Jun; 124(3):556-62. PubMed ID: 9647481
[TBL] [Abstract][Full Text] [Related]
10. Characterization of a 5-hydroxytryptamine receptor in mouse neuroblastoma N18TG2 cells.
Unsworth CD; Molinoff PB
J Pharmacol Exp Ther; 1994 Apr; 269(1):246-55. PubMed ID: 8169832
[TBL] [Abstract][Full Text] [Related]
11. Cloning and expression of ligand-gated ion-channel receptor L2 in central nervous system.
Houtani T; Munemoto Y; Kase M; Sakuma S; Tsutsumi T; Sugimoto T
Biochem Biophys Res Commun; 2005 Sep; 335(2):277-85. PubMed ID: 16083862
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological characteristics of the newly cloned rat 5-hydroxytryptamine2F receptor.
Wainscott DB; Cohen ML; Schenck KW; Audia JE; Nissen JS; Baez M; Kursar JD; Lucaites VL; Nelson DL
Mol Pharmacol; 1993 Mar; 43(3):419-26. PubMed ID: 8450835
[TBL] [Abstract][Full Text] [Related]
13. Cloning, genomic organization and functionality of 5-HT(7) receptor splice variants from mouse brain.
Gellynck E; Laenen K; Andressen KW; Lintermans B; De Martelaere K; Matthys A; Levy FO; Haegeman G; Vanhoenacker P; Van Craenenbroeck K
Gene; 2008 Dec; 426(1-2):23-31. PubMed ID: 18793707
[TBL] [Abstract][Full Text] [Related]
14. The loop C region of the murine 5-HT3A receptor contributes to the differential actions of 5-hydroxytryptamine and m-chlorophenylbiguanide.
Suryanarayanan A; Joshi PR; Bikádi Z; Mani M; Kulkarni TR; Gaines C; Schulte MK
Biochemistry; 2005 Jun; 44(25):9140-9. PubMed ID: 15966738
[TBL] [Abstract][Full Text] [Related]
15. Mouse 5-hydroxytryptamine5A and 5-hydroxytryptamine5B receptors define a new family of serotonin receptors: cloning, functional expression, and chromosomal localization.
Matthes H; Boschert U; Amlaiky N; Grailhe R; Plassat JL; Muscatelli F; Mattei MG; Hen R
Mol Pharmacol; 1993 Mar; 43(3):313-9. PubMed ID: 8450829
[TBL] [Abstract][Full Text] [Related]
16. The binding of propranolol at 5-hydroxytryptamine1D beta T355N mutant receptors may involve formation of two hydrogen bonds to asparagine.
Glennon RA; Dukat M; Westkaemper RB; Ismaiel AM; Izzarelli DG; Parker EM
Mol Pharmacol; 1996 Jan; 49(1):198-206. PubMed ID: 8569707
[TBL] [Abstract][Full Text] [Related]
17. Relaxin-3, INSL5, and their receptors.
Liu C; Lovenberg TW
Results Probl Cell Differ; 2008; 46():213-37. PubMed ID: 18236022
[TBL] [Abstract][Full Text] [Related]
18. Molecular cloning and pharmacological characterization of serotonin 5-HT(3A) receptor subtype in dog.
Jensen TN; Nielsen J; Frederiksen K; Ebert B
Eur J Pharmacol; 2006 May; 538(1-3):23-31. PubMed ID: 16647053
[TBL] [Abstract][Full Text] [Related]
19. Decreased agonist, but not antagonist, binding to the naturally occurring Thr92Lys variant of the h5-HT7(a) receptor.
Brüss M; Kiel S; Bönisch H; Kostanian A; Göthert M
Neurochem Int; 2005 Aug; 47(3):196-203. PubMed ID: 15896881
[TBL] [Abstract][Full Text] [Related]
20. Comparison of [3H]YM060 binding to native and cloned rat 5-HT3 receptors.
Akuzawa S; Miyake A; Miyata K; Fukutomi H
Eur J Pharmacol; 1996 Jan; 296(2):227-30. PubMed ID: 8838461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
